← back to search

Yujun Luo

Huizhou Central People's Hospital · CN
Area of research
Epidemiology · Molecular Biology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Heme Oxygenase-1 and Carbon Monoxide, Medical Research and Treatments, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
4
citations
70
works
20
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles
Theranostics 2023cited by 50position: middledoi
Association Between the Serum Copper Levels and Environmental Tobacco Exposure on the Risk of Overweight and Obesity in Children: a Study Based on the National Health and Nutrition Examination Survey
Biological Trace Element Research 2023cited by 5position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Hao Chen · Nanjing University of Science and Technology1 papers (2023–2023)Jingwei Li · Guangzhou University of Chinese Medicine1 papers (2023–2023)Weihong Sha · Sun Yat-sen University Cancer Center1 papers (2023–2023)Rui Jiang · Fudan University1 papers (2023–2023)Xiaohong Lin · Guangzhou University of Chinese Medicine1 papers (2023–2023)Ruijie Zeng · Southern Medical University1 papers (2023–2023)Zewei Zhuo · Jilin University1 papers (2023–2023)Rui Wei · Southern Medical University1 papers (2023–2023)Zelin Weng · Guangzhou University of Chinese Medicine1 papers (2023–2023)Linzhu Zhang · Guangzhou University of Chinese Medicine1 papers (2023–2023)Yuliang Feng · Jackson Laboratory1 papers (2023–2023)Huihuan Wu · Southern Medical University1 papers (2023–2023)Qi Yang · Rutgers, The State University of New Jersey1 papers (2023–2023)Youjia Xu · Guangzhou University of Chinese Medicine1 papers (2023–2023)Kehang Guo · Southern Medical University1 papers (2023–2023)Qizhou Lian · Sichuan Cancer Hospital1 papers (2023–2023)Yanting Lu · Guangzhou University of Chinese Medicine1 papers (2023–2023)